Opus Genetics, Inc.
IRD
$3.61
-$0.11-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -65.00% | -44.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -65.00% | -44.19% | |||
| Cost of Revenue | 6.01% | 0.47% | |||
| Gross Profit | -24.42% | -26.77% | |||
| SG&A Expenses | 1.39% | 23.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.32% | 7.85% | |||
| Operating Income | -14.73% | -25.42% | |||
| Income Before Tax | 87.64% | -296.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 87.64% | -296.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 87.64% | -296.63% | |||
| EBIT | -14.73% | -25.42% | |||
| EBITDA | -14.74% | -25.45% | |||
| EPS Basic | 88.76% | -267.90% | |||
| Normalized Basic EPS | 88.76% | -267.99% | |||
| EPS Diluted | 81.57% | -267.90% | |||
| Normalized Diluted EPS | 90.37% | -267.99% | |||
| Average Basic Shares Outstanding | 9.89% | 7.83% | |||
| Average Diluted Shares Outstanding | 28.19% | 7.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||